Wiredja Online News Logo

WiredJa Online News

Wiredja Online News Logo

WiredJa Online News

Cuban drug among those used to fight coronavirus in China

  • Written by wiredja.com
  • Published in Health
HAVANA, Cuba, February 12, 2020 - The recombinant Interferon alfa 2B antiviral (IFNrec), a leading biotechnology product in Cuba, is one of the medicines today used by China in treatments applied to patients with the 2019 coronavirus epidemic, according to a tweet from the Cuban embassy in the Asian country.
 
The Chinese-Cuban #Changheber plant in #Jilin has been producing the Interferon alpha (IFNrec) from the first day of the #NewLunar Year, with the use of Cuban technology. The Health Commission # ChinauD83CuDDE8uD83CuDDF3 has selected our product among those used in the fight against #coronavirus, the Twitter message refers.

Prensa Latina, in communiqué from Beijing, reported that since January 25, the ChangHeber mixed plant, located in the town of Changchun, Jilin province, produces the drug because it is one of about 30 chosen by the National Health Commission for its potential to cure the respiratory condition.

According to the ambassador, Carlos Miguel Pereira, the IFNrec is applied against viral infections caused by HIV, recurrent respiratory papillomatosis caused by human papillomavirus, accumulated condyloma, and hepatitis types B and C. It is also effective in therapies against different types of cancer.

The ChangHeber company, together with Biotech and Changchun Heber Biological Technology, are the result of the Cuba and China cooperation in biotechnology, a sector with broad prospects for the implementation of joint projects.
 
China battles tirelessly against the coronavirus 2019-nCoV and its consequent pneumonia, which has caused more than 564 dead, 28 thousand 60 infected and forced to decree the maximum emergency in 31 of its 34 administrative demarcations.
The complexity of the epidemiological situation led the World Health Organization to declare a week ago the international emergency, with the concern that it will spread to countries with weak health systems.
 
In the absence of an effective vaccine, it applies to patients a combination of antivirals with products of traditional Chinese medicine, western drugs and equipment such as respirators, blood filters and so-called artificial lungs.

Jointly, it also undergoes clinical trials with the remdesivir, which is used against Ebola; chloroquine phosphate, a pill against malaria; ritonavir, used to treat HIV / AIDS infections, and Zavesca, effective in the breakdown of certain lipids.
 
-30-
  • Countries: Cuba